Health technology assessment plays a big role in the adoption of medical technologies in Europe. However, due to a large number of HTA organizations and the complexity of HTA schemes, the activity and their impact on reimbursement and funding decisions is not well understood.
We developed an overview of all non-drug HTAs in 2019 to help the industry to understand the HTA landscape, the role of individual HTA organizations, their activity in relation to the number of HTA reports and types of technologies covered.
The report is delivered in the Acrobat PDF version.
The report summarizes information about HTA activity in 12 European countries (+EUnetHTA), including 51 HTA organizations.
Data for all non-pharmaceutical published HTAs in 2019 are reported. In total, 256 reports are reported (in 2018, 337 reports were released by the same organizations).
The largest number of reports were published in England (108 reports, 42%), Sweden (34 reports, 13%) and Spain (26 reports, 10%).
All reports are classified using 31 technological groups. The most common types of technologies covered by HTA reports were in-vitro diagnostic (38 reports, 15%) and cardiovascular (25 reports, 10%) ones.
Download sample pages and request a quote here.